177 related articles for article (PubMed ID: 34834277)
1. Development of Breast Cancer Spheroids to Evaluate Cytotoxic Response to an Anticancer Peptide.
Cavaco M; Fraga P; Valle J; Andreu D; Castanho MARB; Neves V
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834277
[TBL] [Abstract][Full Text] [Related]
2. Development and cytotoxic response of two proliferative MDA-MB-231 and non-proliferative SUM1315 three-dimensional cell culture models of triple-negative basal-like breast cancer cell lines.
Dubois C; Dufour R; Daumar P; Aubel C; Szczepaniak C; Blavignac C; Mounetou E; Penault-Llorca F; Bamdad M
Oncotarget; 2017 Nov; 8(56):95316-95331. PubMed ID: 29221130
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Triple-Negative Breast Cancer MDA-MB-231 Cell Spheroid Model.
Huang Z; Yu P; Tang J
Onco Targets Ther; 2020; 13():5395-5405. PubMed ID: 32606757
[TBL] [Abstract][Full Text] [Related]
4. The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines.
Dubois C; Daumar P; Aubel C; Gauthier J; Vidalinc B; Mounetou E; Penault-Llorca F; Bamdad M
J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30901969
[TBL] [Abstract][Full Text] [Related]
5. Potent antitumor activity of cepharanthine against triple-negative breast cancer spheroids compared with tetrandrine.
Kiyomi A; Miyakawa R; Matsumoto J; Yamazaki K; Imai S; Yuan B; Hirano T; Sugiura M
Oncol Lett; 2020 Dec; 20(6):331. PubMed ID: 33101499
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of micellar-like terpolymer nanoparticles with reductively-cleavable cross-links and evaluation of efficacy in 2D and 3D models of triple negative breast cancer.
Monteiro PF; Gulfam M; Monteiro CJ; Travanut A; Abelha TF; Pearce AK; Jerôme C; Grabowska AM; Clarke PA; Collins HM; Heery DM; Gershkovich P; Alexander C
J Control Release; 2020 Jul; 323():549-564. PubMed ID: 32371266
[TBL] [Abstract][Full Text] [Related]
7. Photoimmunotherapy with cetuximab-conjugated gold nanorods reduces drug resistance in triple negative breast cancer spheroids with enhanced infiltration of tumor-associated macrophages.
Emami F; Pathak S; Nguyen TT; Shrestha P; Maharjan S; Kim JO; Jeong JH; Yook S
J Control Release; 2021 Jan; 329():645-664. PubMed ID: 33022330
[TBL] [Abstract][Full Text] [Related]
8. Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expression.
Ballangrud AM; Yang WH; Palm S; Enmon R; Borchardt PE; Pellegrini VA; McDevitt MR; Scheinberg DA; Sgouros G
Clin Cancer Res; 2004 Jul; 10(13):4489-97. PubMed ID: 15240541
[TBL] [Abstract][Full Text] [Related]
9. Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance.
Li J; Fang K; Choppavarapu L; Yang K; Yang Y; Wang J; Cao R; Jatoi I; Jin VX
Clin Epigenetics; 2021 Sep; 13(1):175. PubMed ID: 34535185
[TBL] [Abstract][Full Text] [Related]
10. Citral induced apoptosis in MDA-MB-231 spheroid cells.
Nigjeh SE; Yeap SK; Nordin N; Kamalideghan B; Ky H; Rosli R
BMC Complement Altern Med; 2018 Feb; 18(1):56. PubMed ID: 29433490
[TBL] [Abstract][Full Text] [Related]
11. Effects of α-Mangostin on Viability, Growth and Cohesion of Multicellular Spheroids Derived from Human Breast Cancer Cell Lines.
Scolamiero G; Pazzini C; Bonafè F; Guarnieri C; Muscari C
Int J Med Sci; 2018; 15(1):23-30. PubMed ID: 29333084
[No Abstract] [Full Text] [Related]
12. Comparative Evaluation of the Cytotoxicity of Doxorubicin in BT-20 Triple-Negative Breast Carcinoma Monolayer and Spheroid Cultures.
Ncube KN; Jurgens T; Steenkamp V; Cromarty AD; van den Bout I; Cordier W
Biomedicines; 2023 May; 11(5):. PubMed ID: 37239157
[TBL] [Abstract][Full Text] [Related]
13. Diversity of cell-mediated adhesions in breast cancer spheroids.
Ivascu A; Kubbies M
Int J Oncol; 2007 Dec; 31(6):1403-13. PubMed ID: 17982667
[TBL] [Abstract][Full Text] [Related]
14. Establishment of 2D Cell Cultures Derived From 3D MCF-7 Spheroids Displaying a Doxorubicin Resistant Profile.
Nunes AS; Costa EC; Barros AS; de Melo-Diogo D; Correia IJ
Biotechnol J; 2019 Apr; 14(4):e1800268. PubMed ID: 30242980
[TBL] [Abstract][Full Text] [Related]
15. Activity of trastuzumab emtansine (T-DM1) in 3D cell culture.
Boyer JZ; Phillips GDL; Nitta H; Garsha K; Admire B; Kraft R; Dennis E; Vela E; Towne P
Breast Cancer Res Treat; 2021 Jul; 188(1):65-75. PubMed ID: 34091830
[TBL] [Abstract][Full Text] [Related]
16. Development and verification of a three-dimensional (3D) breast cancer tumor model composed of circulating tumor cell (CTC) subsets.
Anil-Inevi M; Sağlam-Metiner P; Kabak EC; Gulce-Iz S
Mol Biol Rep; 2020 Jan; 47(1):97-109. PubMed ID: 31583566
[TBL] [Abstract][Full Text] [Related]
17. The New Serum-Free OptiPASS
Goisnard A; Dubois C; Daumar P; Aubel C; Depresle M; Gauthier J; Vidalinc B; Penault-Llorca F; Mounetou E; Bamdad M
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919619
[TBL] [Abstract][Full Text] [Related]
18. Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell lines.
Muguruma M; Teraoka S; Miyahara K; Ueda A; Asaoka M; Okazaki M; Kawate T; Kuroda M; Miyagi Y; Ishikawa T
Biochem Biophys Res Commun; 2020 Dec; 533(3):268-274. PubMed ID: 32958246
[TBL] [Abstract][Full Text] [Related]
19. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
20. Generation of multicellular tumor spheroids of breast cancer cells: how to go three-dimensional.
Nagelkerke A; Bussink J; Sweep FC; Span PN
Anal Biochem; 2013 Jun; 437(1):17-9. PubMed ID: 23435308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
